By Oliver Burkeman — 2018
Pollan’s illuminating history of hallucinogenic drugs reveals that their mystical and medical benefits are indivisible.
Read on www.theguardian.com
CLEAR ALL
When Michael Pollan set out to research how LSD and psilocybin (the active ingredient in magic mushrooms) are being used to provide relief to people suffering from difficult-to-treat conditions such as depression, addiction, and anxiety, he did not intend to write what is undoubtedly his most...
6
Explorers are known for the journeys they take. Rosie McKnight explored the vast nonphysical dimensions of consciousness.
1
As one of our most brilliant and clear-eyed explorers of such topics as plant intelligence and how we feed ourselves, Michael will share his luminous insights from what began as investigative reportage and became a very personal interior journey into the mystery of consciousness and the nature of...
The talk will review brain imaging work on the action of psychedelics on the brain and describe the results of a clinical trial assessing psilocybin as a treatment for depression. It will also review the broader societal impact of psychedelic drug-use and discuss its implications.
Dr. Robin Carhart-Harris, of the Neuropsychopharmacology Unit, Imperial College London, discusses research on Psilocybin and how psychedelics could be used in therapy to help with depression, addiction, and other problems of rigid thought patterns.
In May 1953, Aldous Huxley took four-tenths of a gram of mescaline. The mystical and transcendent experience that followed set him off on an exploration that was to produce a revolutionary body of work about the inner reaches of the human mind.
4